Abstract
Dynamic Change of Peripheral Blood WT1-mRNA within Three Cycles of Azacitidine Therapy Predicts Treatment Response in High-Risk Myelodysplastic Syndrome
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have